NEW YORK (GenomeWeb News) - Australia's Peter MacCullum Cancer Centre purchased a license to Open Biosystems' whole genome human lentiviral shRNAmir library, the company said today.
The transaction was made through the company's Open Access RNAi Program. The program gives the hospital access to RNAi technology, updates and upgrades, off-site backups, and a partner-specific technical support team.
The whole-genome resource enables the hospital's 265 investigators to target any gene in the human genome with what Open Biosystems calls improved knockdown efficiency and effectiveness.
Financial details were not disclosed.